Optimizing IL-2 for Immunotherapy — ASN Events

Optimizing IL-2 for Immunotherapy (124729)

Jonathan Sprent 1
  1. Garvan Institute of Medical Research, Sydney, Australia

Optimizing IL-2 for Immunotherapy